Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
FOCUS
|
PRO
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
-
-
-
-
Theravance: Buy This Biopharma On WeaknessChris Lau • Mon, Aug 13, 2012
-
Theravance: Vote Of Confidence?The Value Investor • Tue, Apr 3, 2012 -
-
-
Theravance May Be Moving HigherM. E. Garza • Wed, Nov 9, 2011 -
Theravance: Fairly Balanced Risk / Reward ProfileZacks Investment Research • Thu, Dec 30, 2010 -
-
Theravance Narrows Its LossesZacks Investment Research • Fri, Apr 24, 2009
-
FDA Sets Date for Theravance Drug ReviewBrett Scott • Fri, Jan 11, 2008
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
-
-
-
-
-
-
-
Seth Klarman's Top Stock PicksInsider Monkey • Wed, Feb 20
-
-
-
-
-
-
Tracking Seth Klarman's Baupost Group Holdings - Q3 2012 UpdateJohn Vincent • Wed, Nov 14, 2012
-
-
Theravance's CEO Discusses Q3 2012 Results - Earnings Call TranscriptTue, Oct 30, 2012 • 1 Comment
-
Theravance Inc. CEO Discusses Q3 2010 Results - Earnings Call TranscriptThu, Oct 21, 2010
-
Theravance Inc Q2 2010 Earnings Call TranscriptThu, Jul 22, 2010
-
Theravance Inc. Q1 2010 Earnings Call TranscriptWed, Apr 21, 2010
-
Theravance, Inc. Q3 2009 Earnings Call TranscriptTue, Oct 27, 2009
-
Theravance, Inc. Q4 2008 Earnings Call TranscriptThu, Feb 12, 2009
-
Marketwire (Mon, 8:16AM)
-
Marketwire (May 23, 2013)
-
Marketwire (May 13, 2013)
-
Marketwire (May 10, 2013)
-
Marketwire (Apr 25, 2013)
-
Marketwire (Apr 23, 2013)
-
Marketwire (Apr 22, 2013)
-
Marketwire (Apr 18, 2013)
-
Marketwire (Apr 17, 2013)
-
Marketwire (Apr 17, 2013)
-
at CNBC.com (Apr 15, 2013)
-
Marketwire (Apr 11, 2013)
-
Marketwire (Feb 21, 2013)
-
Marketwire (Feb 13, 2013)
-
Marketwire (Feb 12, 2013)
-
Marketwire (Jan 31, 2013)
THRX vs. ETF Alternatives
Company Description
Theravance is a biopharmaceutical company with a pipeline of internally discovered product candidates. We are focused on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections and... More
